Phase 4 B-cell Lymphoma Clinical Trials

2 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–2 of 2 trials

Recruiting

Phase 4

Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

Relapsed or Refractory B-cell Lymphoma

Ruijin Hospital8 enrolled1 locationNCT05806580

Recruiting

Phase 3Phase 4

Outpatient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients > 60 years with relapsed or refractory CD20 positive diffuse large B-cell lymphoma who are not candidates for stem cell transplant study

Relapsed or refractory CD20 positive diffuse large B-cell lymphoma

Roche40 enrolled1 locationACTRN12606000373572